Preparation of MPEG-PLA nanoparticle for honokiol delivery in vitro

International Journal of Pharmaceutics

Volumn 386, Issue 1-2, 2010, Pages 262-267

  Zheng, XiuLing ^a   Kan, Bing ^a   Gou, MaLing ^a   Fu, ShaoZhi ^a   Zhang, Juan ^a   Men, Ke ^a   Chen, LiJuan ^a   Luo, Feng ^a   Zhao, YingLan ^a   Zhao, Xia ^a   Wei, YuQuan ^a   Qian, ZhiYong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Honokiol; MPEG PLA; Nanoparticles; Solvent extract method

Indexed keywords

HONOKIOL; MONOMETHOXY POLY(ETHYLENE GLYCOL); POLYLACTIC ACID; POLYMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG RELEASE; ENCAPSULATION; GEL PERMEATION CHROMATOGRAPHY; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; MOLECULAR WEIGHT; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RING OPENING METATHESIS POLYMERIZATION; SOLVENT EXTRACTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIPHENYL COMPOUNDS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, GEL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; FEMALE; HEMOLYSIS; HUMANS; KINETICS; LIGNANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; NANOPARTICLES; NANOTECHNOLOGY; OVARIAN NEOPLASMS; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS; SOLUBILITY; SOLVENTS; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL;

EID: 74249107837     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.11.014     Document Type: Article

References (34)

1. Ahn K.S., Sethi G., Shishodia S., Sung B., Arbiser J.L., and Aggarwal B.B. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-KB activation pathway. Mol. Cancer Res. 4 (2006) 621-633
2. Bai X., Cerimele F., Ushio-Fukai M., Waqas M., Campbell P.M., Govindarajan B., Der C.J., Battle T., Frank D.A., Ye K., Murad E., Dubiel W., Soff G., and Arbiser J.L. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J. Biol. Chem. 278 (2003) 35501-35507
3. Battle T.E., Arbiser J., and Frank D.A. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 106 (2005) 690-697
4. Chen L., Zhang Q., Yang G., Fan L., Tang J., Garrard I., Ignatova S., Fisher D., and Sutherland I.A. Rapid purification and scale-up of honokiol and magnolol using high-capacity high-speed counter-current chromatography. J. Chromatogr. A 1142 (2007) 115-122
5. Ganta S., Devalapally H., Shahiwala A., and Amiji M. A review of stimuli-responsive nanocarriers for drug and gene delivery. J. Control. Release 126 (2008) 187-204
6. Dong Y.C., and Feng S.S. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 25 (2004) 2843-2849
7. Gong C.Y., Dong P.W., Shi S., Fu S.Z., Yang J.L., Gou G., Zhao X., Wei Y.Q., and Qian Z.Y. Thermosensitive PEG-PCL-PEG hydrogel controlled drug delivery system: sol-gel-sol transition and in vitro drug release study. J. Pharm. Sci. (2008) 10.1002/jps.21694.2008.12.19
8. Gou M.L., Dai M., Li X.Y., Wang X.H., Gong C.Y., Xie Y., Wang K., Zhao X., Qian Z.Y., and Wei Y.Q. Preparation and characterization of honokiol nanoparticles. J. Mater. Sci.: Mater. Med. 19 (2008) 2605-2608
9. Gou M.L., Li X.Y., Dai M., Gong C.Y., Wang X.H., Xie Y., Deng H.X., Chen L.J., Zhao X., Qian Z.Y., and Wei Y.Q. A novel injectable local hydrophobic drug delivery system: biodegradable nanoparticles in thermo-sensitive hydrogel. Int. J. Pharm. 359 (2008) 228-233
10. Gou, M.L., Gong, C.Y., Zheng, X.L., Wang, X.H., Guo, G., Chen, L.J., Zhao, X., Wei, Y.Q., Qian, Z.Y., 2009a. Polymeric matrix for drug delivery: honokiol loaded PCL-PEG-PCL nanoparticles in PEG-MPEG-PCL thermo-sensitive hydrogel. J. Biomed. Mater. Res. Part A, doi:10.1002/jbm.a.32546.
11. Gou M.L., Zheng X.L., Men K., Zhang J., Wang B.L., Lv L., Wang X.H., Zhao Y.L., Luo F., Chen L.J., Zhao X., Wei Y.Q., and Qian Z.Y. Self-assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micelles. Pharm. Res. 26 (2009) 2164-2173
12. Gou M.L., Zheng L., Zheng X.L., Shi S., Men K., Zhao X., Qian Z.Y., and Wei Y.Q. Poly((-caprolactone)-poly(ethylene glycol)-poly((-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro. Int. J. Pharm. (2009) 10.1016/j.ijpharm.2009.04.007
13. Gref R., Minamitae Y., Peracchia M.T., Trubetskoy V., Torchillin V., and Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263 (1994) 1600-1603
14. Hahm E.R., and Singh S.V. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Mol. Cancer Ther. 6 (2007) 2686-2695
15. Hou W., Chen L., Yang G., Zhou H., Jiang Q., Zhong Z., Hu J., Chen X., Wang X., Yuan Y., Tang M., Wen J., and Wei Y. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models. Phytother. Res. 22 (2008) 1125-1132
16. Jiang Q.Q., Fan L.Y., Yang G.L., Guo W.H., Hou W.L., Chen L.J., and Wei Y.Q. Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model. BMC Cancer 8 (2008) 242-249
17. Kim T.Y., Kim D.W., Chung J.Y., Shin G.S., and Kim S.C. Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin. Cancer Res. 10 (2004) 3708-3716
18. Lee B., Kim C.H., and Moon S.K. Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells. FEBS Lett. 580 (2006) 5177-5184
19. Liou K.T., Shen Y.C., Chen C.F., Tsao C.M., and Tsai S.K. The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. Eur. J. Pharmacol. 475 (2003) 19-27
20. Lo Y.C., Teng C.M., Chen C.F., Chen C.C., and Hong C.Y. Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Biochem. Pharmacol. 47 (1994) 549-553
21. Luo H., Zhong Q., Chen L.J., Qi X.R., Fu A.F., Yang H.S., Yang F., Lin H.G., Wei Y.Q., and Zhao X. Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer. J. Cancer Res. Clin. Oncol. 134 (2008) 937-945
22. Lu W., Zhang Y., Tan Y.Z., Hu K.Li., Jiang X.G., and Fu S.K. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J. Control. Release 107 (2005) 428-448
23. Maruyama Y., and Kuribara H. Overview of the pharmacological features of honokiol. CNS Drug Rev. 6 (2000) 35-44
24. Matsumoto J., Nakada Y., Sakurai K., Nakamura T., and Takahashi Y. Preparation of nanoparticles consisted of poly(l-lactide)-poly(ethylene glycol)-poly(l-lactide) and their evaluation in vitro. Int. J. Pharm. 185 (1999) 93-101
25. Rapoport N. Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Prog. Polym. Sci. 32 (2007) 962-990
26. Riley T., Stolnik S., Heald C.R., Xiong C.D., Garnett M.C., Illum L., Davis S.S., Purkiss S.C., Barlow R.J., and Gellert P.R. Physicochemical evaluation of nanoparticles assembled from poly(lactic acid)-poly(ethylene glycol) (PLA-PEG) block copolymers as drug delivery vehicles. Langmuir 17 (2001) 3168-3174
27. Saffie-Sieverb R., Ogden J., and Parry-Billings M. Nanotechnology approaches to solving the problems of poorly water-soluble drugs. Drug Discov. World (2005) 71-76
28. Service R.F. Nanotechnology takes aim at cancer. Science 310 (2005) 1132-1134
29. Sheu M.L., Liu S.H., and Lan K.H. Honokiol induces calpain mediated glucose regulated protein-94 cleavage and apoptosis in human gastric cancer cells and reduces tumor growth. PLoS ONE 2 (2007) e1096
30. Wagner V., Dullaart A., Bock A.K., and Zweck A. The emerging nanomedicine landscape. Nat. Biotechnol. 24 (2004) 1211-1217
31. Wang X., Yang L., Chen Z., and Shin D.M. Application of nanotechnology in cancer therapy and imaging. CA Cancer J. Clin. 58 (2008) 97-110
32. Wei X.W., Gong C.Y., Shi S., Fu S.Z., Men K., Zeng S., Zheng X.L., Gou M.L., Chen L.J., Qiu L.Y., and Qian Z.Y. Self-assembled honokiol-loaded micelles based on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) copolymer. Int. J. Pharm. 369 (2009) 170-175
33. Xu D., Lu Q., and Hu X. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Lett. 243 (2006) 274-280
34. Zhang Q.Z., Zha L.S., Zhang Y., Jiang W.M., Lu W., Shi Z.Q., Jiang X.G., and Fu S.K. The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats. J. Drug Target. 14 (2006) 281-290